J Korean Med Sci.  2009 Jan;24(Suppl 1):S3-S6. 10.3346/jkms.2009.24.S1.S3.

Asian Leadership in Chronic Kidney Disease

• Becker GJ

• KMID: 1778133
• DOI: http://doi.org/10.3346/jkms.2009.24.S1.S3

Abstract

Asian Pacific countries include those with the highest incidence of renal failure in the world, the richest and poorest economies and unparalleled diversity of economy, culture and geography. From this come many challenges, but also a strong basis for the introduction of strategies to combat renal diseases. With a rapidly developing scientific community, Asia needs to accept the challenge of becoming a global leader in nephrology in the near future.

Keyword

Asian; Kidney Diseases; Kidney Failure

MeSH Terms

Asia
Humans
International Cooperation
Kidney Failure, Chronic/*diagnosis/*epidemiology/ethnology
Nephrology/methods
Prevalence
Public Health
World Health

Figure

• 

  Fig. 1 Exponential increase in renal publications from Asia since 1985. Graph compiled from Pub Med listed articles published (i) between 1985 and 2007 (ii) from authors of institutions in Japan, China, Korea, Taiwan and India (iii) with renal, kidney or nephrology in title, abstract or keywords.

Reference

1. United Nations. World population prospects the 2006 revision. 2006. New York: 37–42.

2. Nominal GPP-list of countries. World economic outlook database. 2007. Data for the year 2007. International Monetary Fund.

3. Karlberg JP. West to East drift in European sponsored clinical trials. Clinical Trial Magnifier. 2008. 1:1–11.

4. Wakai K, Nakai S, Kikuchi K, Iseki K, Miwa N, Masakane I, Wada A, Shinzato T, Nagura Y, Akiba T. Trends in incidence of end-stage renal disease in Japan, 1983-2000: age-adjusted and age-specific rates by gender and cause. Nephrol Dial Transplant. 2004. 19:2044–2052.

5. Kuo HW, Tsai SS, Tiao MM, Yang CY. Epidemiological features of CKD in Taiwan. Am J Kidney Dis. 2007. 49:46–55.

6. Choo WH, Kim HT. Current status of renal replacement therapy in Korea. J Artif Organs. 2003. 6:88–91.

7. The ESRD Incidence Study Group, Stewart JH, McCredie MR, Williams SM. Geographic, ethnic, age-related and temporal variation in the incidence of end-stage renal disease in Europe, Canada and the Asia-Pacific region, 1998-2002. Nephrol Dial Transplant. 2006. 21:2178–2183.

8. Hoy WE, Rees M, Kile E, Mathews JD, Wang Z. A new dimension to the Barker hypothesis: low birthweight and susceptibility to renal disease. Kidney Int. 1999. 56:1072–1077.

9. Nelson RG. Diabetic renal disease in transitional and disadvantaged populations. Nephrology. 2001. 6:9–17.

10. Nelson RG. Intrauterine determinants of diabetic kidney disease in disadvantaged populations. Kidey Int Suppl. 2003. 63:S13–S16.

11. Feehally J. Ethnicity and renal disease. Kidney Int. 2005. 68:414–424.

12. Norris KC, Agodoa LY. Unraveling the racial disparities associated with kidney disease. Kidney Int. 2005. 68:914–924.

13. Hall YN, Hsu CY, Iribarren C, Darbinian J, McCulloch CE, Go AS. The conundrum of increased burden of end-stage renal disease in Asians. Kidney Int. 2005. 68:2310–2316.

14. Cockcroft D, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976. 16:31–41.

15. Levey AS, Eckardt KU, Tsukamoto Y, Levin A, Coresh J, Rossert J, de Zeeuw D, Hostetter TH, Lameire N, Eknoyan G. Definition and classification of chronic kidney disease: a position statement from Kidney Deisease: Improving Global Outcomes (KDIGO). Kidney Int. 2005. 67:2089–2100.

16. Imai E, Horio M, Nitta K, Yamagata K, Iseki K, Tsukamoto Y, Ito S, Makino H, Hishida A, Matsuo S. Modification of the modification of diet in renal disease (MDRD) study equation for Japan. Am J Kidney Dis. 2007. 50:927–937.

17. Ma YC, Zuo L, Chen JH, Luo Q, Yu XQ, Li Y, Xu JS, Huang SM, Wang LN, Huang W, Wang M, Zu GB, Wang HY. Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J Am Soc Nephrol. 2006. 17:2937–2944.

18. Kang YS, Han KH, Han SY, Kim HK, Cha DR. Characteristics of population with normal serum creatinine impaired renal function and: the validation of a MDRD formula in a healthy general population. Clin Nephrol. 2005. 63:258–266.

19. Rizvi SA. Present state of dialysis and transplantation in Pakistan. Am J Kidey Dis. 1998. 31:14–18.

20. Chugh KS, Sakhuja V, Malhotra HS, Pereira BJ. Changing trends in acute renal failure in third-world countries-Chandigarh Study. Q J Med. 1989. 73:1117–1123.

21. Chugh KS, Jha V, Chugh S. Tropical acute renal failure. Kidney: a Current Survey of World Literature. 1998. 7:43–47.

22. Sitprija V. Snakebite nephropathy. Nephrology (Carlton). 2006. 11:442–448.

23. Wiwanitkit V. Renal failure from wasp stings: an appraisal on the previous reported Thai cases. Nephrology (Carlton). 2005. 10:537.

24. Jha V, Chugh KS. Nephropathy associated with animal, plant, and chemical toxins in the tropics. Semin Nephrol. 2003. 23:49–65.

25. Lai KN, Aarons I, Woodroffe AJ, Clarkson AR. Renal lesions in leptospirosis. Aust N Z J Med. 1982. 12:276–279.

26. Visith S, Kearkiat P. Nephropathy in leptospirosis. J Postgrad Med. 2005. 51:184–188.

27. Wiwanitkit V. Acute renal failure in the fatal cases of dengue hemorrhagic fever, a summary in Thai death cases. Ren Fail. 2005. 27:647.

28. Lee HW. Haemorrhagic fever with renal syndrome: an emerging disease. Nephrology (Carlton). 1996. 2:S88–S93.

29. Kim YK, Lee SC, Kim C, Heo ST, Choi C, Kim JM. Clinical and laboratory predictors of oliguric renal failure in haemorrhagic fever with renal syndrome caused by Hantaan virus. J Infect. 2007. 54:381–386.

30. Ko KW. Haemorrhagic fever with renal syndrome: clinical aspects. Pediatr Nephrol. 1992. 6:197–200.

31. Teeyakasem W, Nishijo M, Honda R, Satarug S, Swaddiwudhipong W, Ruangyuttikarn W. Monitoring of cadmium toxicity in a Thai population with high-level environmental exposure. Toxicol Lett. 2007. 169:185–195.

32. Yu CC, Lin JL, Lin-Tan DT. Environmental exposure to lead and progression of chronic renal diseases: a four-year prospective longitudinal study. J Am Soc Nephrol. 2004. 15:1016–1022.

33. Parry J. Contaminated infant formula sickens 6200 babies in China. BMJ. 2008. 337:a1738.

34. Howard JK, Sabapathy NN, Whitehead PA. A study of the health of Malaysian plantation workers with particular reference to paraquat spraymen. Br J Ind Med. 1981. 38:110–116.

35. West CE, Perrin DD, Shaw DC, Heap GH, Soemanto . Djenkol bean poisoning (djenkolism): proposals for treatment and prevention. Southeast Asian J Trop Med Public Health. 1973. 4:564–570.

36. Segasothy M, Swaminathan M, Kong NC, Bennett WM. Djenkol bean poisoning (djenkolism): an unusual cause of acute renal failure. Am J Kidney Dis. 1995. 25:63–66.

37. Eiam-Ong S, Sitprija V. Tropical plant-associated nephropathy. Nephrology (Carlton). 1998. 313–320.

38. Phakdeekitcharoen B, Ruangraksa C, Radinahamed P. Hypokalaemia and paralysis in the Thai population. Nephrol Dial Transplant. 2004. 19:2013–2018.

39. Erasmus RT, Lavu EK, Savory J, Wills M. Hypokalaemic paralysis associated with renal tubular acidosis. PNG Med J. 1997. 40:173–176.

40. Brown N, Polume H. Renal tubular acidosis in Papua New Guinea. PNG Med J. 1994. 37:45–49.

41. Burling F, Ng J, Thein H, Ly J, Marshall MR, Gow P. Ethnic, clinical and immunological factors in systemic lupus erythematosus and the development of lupus nephritis: results from a multi-ethnic New Zealand cohort. Lupus. 2007. 16:830–837.

42. Patel M, Clarke AM, Bruce IN, Symmons DP. The prevalence and incidence of biopsy-proven lupus nephritis in the UK: evidence of an ethnic gradient. Arthritis Rheum. 2006. 54:2963–2969.

43. Serdula MK, Rhoads GG. Frequency of systemic lupus erythematosus in different ethnic groups in Hawaii. Arthritis Rheum. 1979. 22:328–333.

44. Lee HS, Koh HI, Lee HB, Park HC. IgA nephropathy in Korea: a morphological and clinical study. Clin Nephrol. 1987. 27:131–140.

45. Hall YN, Fuentes EF, Chertow GM, Olson JL. Race/ethnicity and disease severity in IgA nephropathy. BMC Nephrol. 2004. 5:10.